Connect with us
[the_ad id="89560"]

COVID-19

Canada to unveil travel rules for fully vaccinated citizens, permanent residents

Published

4 minute read

OTTAWA — Canada is set to detail what quarantine rules citizens and permanent residents who are fully vaccinated against COVID-19 will soon have to follow when entering the country.

Public Safety and Emergency Preparedness Minister Bill Blair said last week that “measures” would be announced today that will apply to immunized Canadians, as well as foreign nationals who are permitted entry.

Currently, those without citizenship or resident status can enter the country only if their travel is related to work, school or other essential business, but not for leisure.

As more Canadians get inoculated against COVID-19 and summer weather  has people itching to take some long-awaited trips, pressure is building for the Liberal government to begin relaxing some of its border and quarantine rules.

Over the weekend the country hit an important target of having 75 per cent of its eligible population receive one dose and 20 per cent get two, providing the latter group with full protection against COVID-19.

These were benchmarks Prime Minister Justin Trudeau and top health officials said needed to be met to safely relax pandemic-related health measures.

Those hoping to see some loosening this month were disappointed on Friday when the Liberal government announced its restrictions on non-essential international travel would remain in place at the Canada-U.S. border until July 21.

In the lead up to Monday’s announcement, the federal government spent the past week teasing at some of the travel changes it considered making for vaccinated Canadians and permanent residents.

Health Minister Patty Hajdu has said that starting in early July, the government looked to exempt fully vaccinated travellers from having to pay for a three-night stay at a government-approved hotel.

The sites are where Canadians entering the country by air, regardless of their vaccination status, must currently begin a 14-day quarantine while awaiting a negative result from a COVID-19 test required upon arrival.

Among the Canadians who recently went through the process was Trudeau himself, who’s currently in quarantine after spending five days in Europe attending international meetings with G7 and NATO leaders.

The prime minister said that in terms of being able to show border security some proof of vaccination, the country would rely on Canadians uploading images of their records to its ArriveCAN app, which is where returning travellers already have to share where they will stay for their 14 days of quarantine.

Both he and Hajdu say the country’s border rules would be relaxed in phases.

In particular, Hajdu has said the government intends those who are fully vaccinated to still be tested for COVID-19 before leaving for Canada and again on their return, where they would also need a plan for where to quarantine while awaiting a negative result.

An expert panel comprised mainly of doctors that studied Canada’s COVID-19 border measures recently recommended the government scrap hotel quarantines altogether for fully vaccinated travellers, provided they test negative for the virus and have proof they have been inoculated.

As for those with one dose, the doctors suggested travellers quarantine at home until receiving their negative COVID-19 test after having a swab done before departure.

And for those who haven’t been vaccinated at all, the panel said they should be allowed to leave quarantine if they test negative before departure, upon arrival and seven days into the full two-week self-isolation period.

This report by The Canadian Press was first published June 21, 2021

Stephanie Taylor, The Canadian Press

Storytelling is in our DNA. We provide credible, compelling multimedia storytelling and services in English and French to help captivate your digital, broadcast and print audiences. As Canada’s national news agency for 100 years, we give Canadians an unbiased news source, driven by truth, accuracy and timeliness.

Follow Author

Brownstone Institute

FOIA Doc Shows BioNTech Founders Postdated Start of C19 Vax Project

Published on

From the Brownstone Institute

BY Robert KogonROBERT KOGON

As noted in my last article on BioNTech’s “brazen” avoidance of safety testing of its Covid-19 vaccine, BioNTech founders Ugur Sahin and Özlem Türeci claim in their book The Vaccine that the company’s Covid-19 vaccine project got underway on January 27, 2020. But documentary evidence released in response to a FOIA request (and included in the so-called “Pfizer documents”) shows that this is not true and that the company had in fact already begun preclinical, i.e. animal, testing nearly two weeks earlier, on January 14.

BioNTech R&D STUDY REPORT No. R-20-0072 is available here. The report is also referenced and discussed in an FDA submission on the preclinical study program that is available here. The below screenshot shows the study dates from p. 8 of the report.

In the book, Sahin claims furthermore that he only even became interested in the outbreak in Wuhan on January 24, after reading an article in the German weekly Der Spiegel (p. 4) and/or a submission to The Lancet (p. 6). But look again at the study dates above. BioNTech had already completed the first preclinical study for its Covid-19 vaccine the day before!

January 24, 2020 was a Friday. On Sahin’s account, he took the decision to launch his Covid-19 vaccine project over the weekend and unveiled his plans to his collaborators at BioNTech’s headquarters in Mainz, Germany on the following Monday: January 27 (ch. 2 passim and p. 42; see screencap below).

Sahin claims (p. 33) that it was at this January 27 meeting that he asked BioNTech’s animal testing team to prepare the preclinical program that was in fact already underway!

It should be noted that January 14, 2020, the start-date of the first preclinical study, was just two weeks after the first report of Covid-19 cases in Wuhan and just a day after the release of the full SARS-CoV-2 genome (drafts had been released previously).

BioNTech’s first preclinical study was evidently prepared before publication of the genome and in anticipation of it. As explained in the summary of the study (p. 6), its purpose was to test BioNTech mRNA formulated in lipid nanoparticles produced by the Canadian firm Acuitas. But the mRNA was here encoding a proxy antigen (luciferase), not the spike protein of SARS-CoV-2 that would later serve as the target antigen.

The study looked at both biodistribution and immune system activation. As the FDA submission on the preclinical program puts it, “Platform properties that support BNT162b2 were initially demonstrated with non-SARS-CoV-2 antigens” (2.4 NONCLINICAL OVERVIEW, p. 7).

In The Vaccine, which was written with the journalist Joe Miller, Sahin and Türeci talk about the need to obtain the Acuitas lipids, which, they say, were more suitable for intramuscular injection than BioNTech’s own in-house lipids. But, again, they postdate the matter. Thus, on p. 52, we read: “The missing piece was still Acuitas, who had not yet consented to the use of their lipids. Then, on the morning of Monday 3 February, [Acuitas CEO] Tom Madden offered his help.” But BioNTech was already running tests using the Acuitas lipids three weeks earlier!

Furthermore, BioNTech was not able to formulate its mRNA into the lipids itself, but depended on the Austrian company Polymun to do this for it. As noted in The Vaccine (p.51), Polymun’s facilities are an 8-hour drive from BioNTech’s headquarters in Mainz. In the book, Sahin and Türeci describe the first batch of mRNA for the vaccine tests proper being packed up and driven by car to Polymun outside Vienna: “A couple of days later, a small Styrofoam box containing frozen vials full of vaccine would be driven back over the border to BioNTech” (pp. 116-117).

But presumably this same back-and-forth had to have occurred with the mRNA encoding the luciferase. This means that as a practical matter “Project Lightspeed” must have gotten underway even earlier: at least several days before the January 14 start date of the study.

Why did Sahin and Türeci postdate the launch of their Covid-19 vaccine project in their book? Well, undoubtedly because the actual start date – and we do not know when exactly the actual start date was – would have seemed far too soon. Based on the above considerations, it must have been at the latest just days after the first December 31, 2019 report of Covid-19 cases in Wuhan.

Author

  • Robert Kogon

    Robert Kogon is a pen name for a widely-published financial journalist, a translator, and researcher working in Europe. Follow him at Twitter here. He writes at edv1694.substack.com.

Continue Reading

Alberta

Preston Manning picked to chair review of Alberta’s COVID response

Published on

Premier Danielle Smith has struck a committee to investigate how the Alberta government responded to the COVID-19 pandemic and has appointed former Reform Party leader Preston Manning to chair it.

Smith, in a statement, says Manning and the panel will take feedback virtually from experts and the public, then issue a final report and recommendations by Nov. 15.

Manning is to pick the other panel members subject to approval by Smith.

The budget is $2 million, and Manning is to be paid $253,000.

Manning and Smith have been critical of government-imposed health restrictions such as masking, gathering rules and vaccine mandates during the pandemic.

Smith has questioned the efficacy of the methods and their long-term effects on household incomes, the economy and mental health.

She has criticized both Dr. Deena Hinshaw, the former chief medical officer of health, and the Alberta Health Services board for failing to provide good advice and help prepare for the pandemic, which she says forced the government to impose health restrictions and vaccine mandates.

Smith replaced Hinshaw and the board shortly after taking office in October.

The premier said Alberta needs to be ready for future health emergencies.

“There are valuable lessons we learned from the Alberta government’s response to the COVID-19 public health emergency,” Smith said in the statement Thursday.

“It’s important that we apply those lessons to strengthen our management of future public health crises, and the panel’s recommendations will be key in doing so.”

This report by The Canadian Press was first published Jan. 19, 2022.

Continue Reading

Trending

X